Acorah Software Products - Accounts Production 19.2.450 true true 31 May 2025 1 June 2024 false true No description of principal activity 1 June 2025 31 May 2026 31 May 2026 12601249 Mr I Hamdulay iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12601249 2025-05-31 12601249 2026-05-31 12601249 2025-06-01 2026-05-31 12601249 frs-core:CurrentFinancialInstruments 2026-05-31 12601249 frs-bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 12601249 frs-bus:FilletedAccounts 2025-06-01 2026-05-31 12601249 frs-bus:Micro-entities 2025-06-01 2026-05-31 12601249 frs-bus:EntityHasNeverTraded 2025-06-01 2026-05-31 12601249 frs-bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 12601249 frs-bus:Director1 2025-06-01 2026-05-31 12601249 2024-05-31 12601249 2025-05-31 12601249 frs-core:CurrentFinancialInstruments 2025-05-31
Registered number: 12601249
Immunehealth Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2026
Immunehealth Ltd
Balance Sheet
As At 31 May 2026
Balance Sheet
Registered number: 12601249

| 2026 | 2025
--- | --- | ---
|  | £ | £
Creditors: Amounts Falling Due Within One Year |  | (3,041 ) | (2,681 )
NET CURRENT LIABILITIES |  | (3,041 ) | (2,681 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  | (3,041 ) | (2,681 )
NET LIABILITIES |  | (3,041 ) | (2,681 )
CAPITAL AND RESERVES |  | (3,041 ) | (2,681 )

## Notes

1. General Information
Immunehealth Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12601249 . The registered office is 33 ARBUTUS DRIVE, COOMBE DINGLE, BRISTOL, AVON, BS9 2PW.
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mr I Hamdulay Director
09/07/2026